Nasdaq tmdx.

Find real-time TMDX - Transmedics Group Inc stock quotes, company profile, ... Transmedics Group Inc (NASDAQ:TMDX) Real-Time Quotes. 60.81. BATS BZX Real-Time Price. As of 12:06pm ETNasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies Stocks276,036. 5.445315. Back to TMDX Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end ...According to the issued ratings of 8 analysts in the last year, the consensus rating for TransMedics Group stock is Moderate Buy based on the current 1 hold rating and 7 buy ratings for TMDX. The average twelve-month price prediction for TransMedics Group is $79.83 with a high price target of $110.00 and a low price target of $54.00.

"The third quarter was a critical execution period for TMDX as we integrated a new business, expanded our NOP clinical support capacity, and launched a first-of-its kind business to expand our NOP ...

TransMedics Group, Inc. (NASDAQ:TMDX) has a long runway of growth left ahead of it. Sitting at just under $2B market cap, TransMedics seems likely to have multi-bagger potential over the next few ...

Entering text into the input field will update the search result belowTransMedics Group Inc (NASDAQ:TMDX) reported Q3 revenues of $66.4 million, a 159% Y/Y increase, beating the consensus of $49.19 million.. The increase was due primarily to greater utilization of ...Aug 3, 2023 · ANDOVER, Mass., Aug. 3, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... NASDAQ: TransMedics Group Inc (TMDX) = 74.66 USD. Provided by Alpha Vantage. TransMedics Group Inc stock (TMDX) in USD. 1 TMDX = 74.66 USD. 1 month. 6 months. 1 year. 5 years. Hold over 40 currencies to convert and send money at any time. Open an account. TransMedics Group Inc stock performance at a glance.

ANDOVER, Mass., Nov. 3, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on November 1, 2023, TransMedics granted non-qualified stock options to purchase an …

TransMedics Group, Inc. (NASDAQ:TMDX) has been a great call over the last 6–8 months since my original publication back in August. Since then, TMDX stock has repriced >100% to the upside and ...

Find the latest Insider Activity data for TransMedics Group, Inc. Common Stock (TMDX) at Nasdaq.com.The Weiss investment rating of TransMedics Group, Inc. (NASDAQ: TMDX) is D-.TransMedics Group (NASDAQ: TMDX) fool.com - August 19 at 11:22 PM: Spouting Rock Asset Management LLC Lowers Stake in TransMedics Group, Inc. (NASDAQ:TMDX) marketbeat.com - August 18 at 9:41 AM: TransMedics (TMDX) Acquires Summit Aviation for Organ Transplant finance.yahoo.com - August 17 at 6:32 PMTransMedics Group, Inc. (NASDAQ:TMDX) is a Massachusetts-based commercial-stage medical technology company, engaged in transforming organ transplant therapy for end-stage organ failure patients in ...Reported on 11/6/23. Get the latest TransMedics Group Inc (TMDX) real-time quote, historical performance, charts, and other financial information to help you make more …

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...TransMedics Group, Inc. (NASDAQ:TMDX) is a Massachusetts-based commercial-stage medical technology company, engaged in transforming organ transplant therapy for end-stage organ failure patients in ...TransMedics (“TMDX”), headquartered in Andover, MA, is a leader in normothermic machine perfusion technology utilized for organ preservation during the organ transplant process. TransMedics ...ANDOVER, Mass., Nov. 11, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...Nasdaq 14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement TransMedics Group, Inc. (TMDX) NasdaqGM - NasdaqGM...Founded in 1998 by President and CEO Waleed Hassanein, TransMedics Group (TMDX 3.88%) has quickly become one of the easiest stocks to root for of our time by revolutionizing the organ donation and ...

Hamilton Thorne (OTCMKTS:HTLZF – Get Free Report) and TransMedics Group (NASDAQ:TMDX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership and …

Aug 1, 2022 · NasdaqGM:TMDX Earnings and Revenue Growth August 1st 2022. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences ... (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and ...TransMedics Group Inc ( NASDAQ:TMDX) reported a 159% increase in net revenue for Q3 2023, reaching $66.4 million. The acquisition of Summit Aviation contributed to an incremental transplant ...Nov 24, 2023 · TransMedics Group, Inc. (NASDAQ:TMDX) posted its quarterly earnings data on Monday, November, 6th. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.06. The business earned $66.43 million during the quarter, compared to analysts' expectations of $48.05 million. ANDOVER, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for ...Nov 23, 2023 · The stock of Transmedics Group Inc (NASDAQ: TMDX) has increased by 1.56 when compared to last closing price of 67.89. Despite this, the company has experienced a 5.12% gain in its stock price over the last five trading sessions. The Motley Fool reported 2023-11-09 that TransMedics Group’s transplant organ retrieval and delivery business is accelerating […] TransMedics Group, Inc. 01 Mar, 2021, 16:15 ET. ANDOVER, Mass., March 1, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is ...

SENTIMENT. 07/23/2020 08:00 AM. TMDX : Nasdaq. TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020. conferences earnings. IMPACT.

05 Jan, 2022, 18:41 ET. ANDOVER, Mass., Jan. 5, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is transforming organ transplant ...

TransMedics Group, Inc. (NASDAQ:TMDX) has been making waves in the medical technology sector with its organ care system platform development and commercialization. The company has recently earned a consensus rating of “Moderate Buy” from seven brokerages that are currently covering the firm, according to Bloomberg reports.Aug 3, 2023 · ANDOVER, Mass., Aug. 3, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... The grants were approved by the Compensation Committee of the TransMedics Board of Directors and were granted in accordance with Nasdaq Listing Rule 5635 (c) (4) and pursuant to the TransMedics Group, Inc. Inducement Plan. TransMedics granted non-qualified stock options to purchase 27,520 shares of TransMedics' common …TransMedics Group (NASDAQ:TMDX) provides organ preservation technology and is a leader in normothermic machine perfusion.Its FDA-approved Organ Care System replicates the body’s physiologic ...TransMedics Group (NASDAQ:TMDX) has gone public in an IPO which has been quite a success, with shares trading more than 50% higher than its offer price as investors like the accelerating growth ...Oct 10, 2023 · ANDOVER, Mass., Oct. 10, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... 2023年11月7日 上午10:15 · 16 分鐘文章. TransMedics Group, Inc. (NASDAQ: TMDX) Q3 2023 Earnings Call Transcript November 6, 2023. Operator: Good afternoon, and welcome to TransMedics Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer ...NASDAQ: TMDX TransMedics Group. Market Cap. $2B. Today's Change (2.92%) $1.95. Current Price. $68.70. Price as of November 17, 2023, 4:00 p.m. ET. ... (TMDX 2.92%). This high-growth stock has been ...ANDOVER, Mass., July 26, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...The Weiss investment rating of TransMedics Group, Inc. (NASDAQ: TMDX) is D-.Based on analysts offering 12 month price targets for TMDX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .In recent months, TransMedics Group (NASDAQ:TMDX) has garnered significant attention from research analysts. Various reports have been published regarding the TransMedics Group Gains Attention with Positive Research Reports and Institutional Investor Interest - Best Stocks

Aug 3, 2023 · ANDOVER, Mass., Aug. 3, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ... Feb 24, 2023 · NASDAQ: TMDX TransMedics Group. Market Cap. $2B. Today's Change (2.92%) $1.95. Current Price. $68.70. Price as of November 17, 2023, 4:00 p.m. ET. ... (TMDX 2.92%). This high-growth stock has been ... २०२३ जुन ५ ... and TransMedics Group (TMDX). ======== TD Ameritrade Network ... Nasdaq•9.2K views · 7:42. Go to channel · Risks in the Bond Market: Short ...Instagram:https://instagram. mandt home equity line of creditva second tier entitlementalphasimplex managed futurestd banks stock ANDOVER, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for ...TransMedics Group, Inc. (NASDAQ:TMDX) has been a great call over the last 6–8 months since my original publication back in August. Since then, TMDX stock has repriced >100% to the upside and ... g. d.usaa have pet insurance TransMedics also has just under $60 million in long-term debt as well as some $445 in senior convertible notes. The company netted approximately $393 million from this transaction. The latter was ... affordable catastrophic health insurance TransMedics Group, Inc. Prices $400 Million of Convertible Senior Notes Due 2028. ANDOVER, Mass. , May 8, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-st... 7 months ago - PRNewsWire.The market capitalization of TMDX is $1.7 billion. TMDX has shown promising earnings growth, with a growth rate of 23.44% in the previous year and 63.95% this year. TMDX’s revenue growth in the last year was remarkable, standing at 208.83%. The Price/Sales ratio for TMDX is 19.52, and the Price/Book ratio is 8.86.TransMedics (“TMDX”), headquartered in Andover, MA, is a leader in normothermic machine perfusion technology utilized for organ preservation during the organ transplant process. TransMedics ...